View in EDS

Discovery of Diphenylacetamides as CXCR7 Inhibitors with Novel β-Arrestin Antagonist Activity.

Saved in:
Bibliographic Details
Title: Discovery of Diphenylacetamides as CXCR7 Inhibitors with Novel β-Arrestin Antagonist Activity.
Authors: Menhaji-Klotz E; Pfizer Worldwide Research & Development, Cambridge, Massachusetts 02139, United States., Ward J; Pfizer Worldwide Research & Development, Cambridge, Massachusetts 02139, United States., Brown JA; Pfizer Worldwide Research & Development, Groton, Connecticut 06340, United States., Loria PM; Pfizer Worldwide Research & Development, Groton, Connecticut 06340, United States., Tan C; Pfizer Worldwide Research & Development, Cambridge, Massachusetts 02139, United States., Hesp KD; Pfizer Worldwide Research & Development, Groton, Connecticut 06340, United States., Riccardi KA; Pfizer Worldwide Research & Development, Groton, Connecticut 06340, United States., Litchfield J; Pfizer Worldwide Research & Development, Cambridge, Massachusetts 02139, United States., Boehm M; Pfizer Worldwide Research & Development, Cambridge, Massachusetts 02139, United States.
Source: ACS medicinal chemistry letters [ACS Med Chem Lett] 2020 May 14; Vol. 11 (6), pp. 1330-1334. Date of Electronic Publication: 2020 May 14 (Print Publication: 2020).
Publication Type: Journal Article
Journal Info: Publisher: American Chemical Society Country of Publication: United States NLM ID: 101521073 Publication Model: eCollection Cited Medium: Print ISSN: 1948-5875 (Print) Linking ISSN: 19485875 NLM ISO Abbreviation: ACS Med Chem Lett Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 32551020
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Discovery of Diphenylacetamides as CXCR7 Inhibitors with Novel β-Arrestin Antagonist Activity.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Menhaji-Klotz+E%22">Menhaji-Klotz E</searchLink>; Pfizer Worldwide Research & Development, Cambridge, Massachusetts 02139, United States.<br /><searchLink fieldCode="AU" term="%22Ward+J%22">Ward J</searchLink>; Pfizer Worldwide Research & Development, Cambridge, Massachusetts 02139, United States.<br /><searchLink fieldCode="AU" term="%22Brown+JA%22">Brown JA</searchLink>; Pfizer Worldwide Research & Development, Groton, Connecticut 06340, United States.<br /><searchLink fieldCode="AU" term="%22Loria+PM%22">Loria PM</searchLink>; Pfizer Worldwide Research & Development, Groton, Connecticut 06340, United States.<br /><searchLink fieldCode="AU" term="%22Tan+C%22">Tan C</searchLink>; Pfizer Worldwide Research & Development, Cambridge, Massachusetts 02139, United States.<br /><searchLink fieldCode="AU" term="%22Hesp+KD%22">Hesp KD</searchLink>; Pfizer Worldwide Research & Development, Groton, Connecticut 06340, United States.<br /><searchLink fieldCode="AU" term="%22Riccardi+KA%22">Riccardi KA</searchLink>; Pfizer Worldwide Research & Development, Groton, Connecticut 06340, United States.<br /><searchLink fieldCode="AU" term="%22Litchfield+J%22">Litchfield J</searchLink>; Pfizer Worldwide Research & Development, Cambridge, Massachusetts 02139, United States.<br /><searchLink fieldCode="AU" term="%22Boehm+M%22">Boehm M</searchLink>; Pfizer Worldwide Research & Development, Cambridge, Massachusetts 02139, United States.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101521073%22">ACS medicinal chemistry letters</searchLink> [ACS Med Chem Lett] 2020 May 14; Vol. 11 (6), pp. 1330-1334. <i>Date of Electronic Publication: </i>2020 May 14 (<i>Print Publication: </i>2020).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Chemical+Society%22">American Chemical Society </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101521073 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1948-5875 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2219485875%22">19485875 </searchLink><i>NLM ISO Abbreviation: </i>ACS Med Chem Lett <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=32551020
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1021/acsmedchemlett.0c00163
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1330
    Titles:
      – TitleFull: Discovery of Diphenylacetamides as CXCR7 Inhibitors with Novel β-Arrestin Antagonist Activity.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Menhaji-Klotz E
      – PersonEntity:
          Name:
            NameFull: Ward J
      – PersonEntity:
          Name:
            NameFull: Brown JA
      – PersonEntity:
          Name:
            NameFull: Loria PM
      – PersonEntity:
          Name:
            NameFull: Tan C
      – PersonEntity:
          Name:
            NameFull: Hesp KD
      – PersonEntity:
          Name:
            NameFull: Riccardi KA
      – PersonEntity:
          Name:
            NameFull: Litchfield J
      – PersonEntity:
          Name:
            NameFull: Boehm M
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 14
              M: 05
              Text: 2020 May 14
              Type: published
              Y: 2020
          Identifiers:
            – Type: issn-print
              Value: 1948-5875
          Numbering:
            – Type: volume
              Value: 11
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: ACS medicinal chemistry letters
              Type: main
ResultId 1